Body¯uids other than blood, urine and cerebrospinal¯uid are often submitted for biochemical analysis. Of these, pleural and peritoneal¯uids are the most common. A wide range of tests may be requested. 1, 2 Sometimes, speci®c questions about the aetiology are being asked ± for example`is it infected?' or`is it malignant?' The question is not always so well de®ned and sometimes there is a suspicion that uid samples are sent to the laboratory for analysis simply because the¯uid has been collected.
This review critically assesses the utility of the wide range of analytes used in the past to investigate pleural¯uid and examines the evidence for using them now. We have attempted to include an overall view of each analyte as well as combinations of analytes and make recommendations for a rational, pragmatic approach to the analysis of pleural¯uid samples sent to the laboratory for evaluation.
PLEURAL FLUID FORMATION
Pleural¯uid is an ultra®ltrate of plasma. Usually there is less than 10 mL of¯uid in each pleural cavity. 3 More than this will accumulate when the rate of¯uid formation exceeds the rate of¯uid removal.
Fluid production is increased if there is:
.
Elevation of the hydrostatic pressure gradient (e.g. in congestive cardiac failure, portal hypertension). .
A decrease in colloid osmotic pressure (e.g. in hypoproteinaemia). .
Increased permeability of the capillary vessels (e.g. in infection, malignancy, in¯ammation).
Fluid removal is decreased if there is:
. Impaired lymphatic drainage (e.g. in some neoplasms). .
Decreased pressure in the pleural space (e.g. in bronchial obstruction, atelectasis).
Blood, pus and chyle may also present as¯uid accumulations.
TRANSUDATE OR EXUDATE?
Traditionally, serous¯uids are classi®ed as transudates or exudates. Transudates derive from ultra®ltration across a membrane and have a low protein content, whereas exudates are formed by active secretion or leakage and have a high protein content. The presence of a transudative effusion implies a non-in¯ammatory process caused by a disturbance of hydrostatic or colloid osmotic pressure with no pleural disease involvement. In contrast, an exudate implies involvement of the pleura by an in¯ammatory or malignant process causing increased capillary permeability.
When pleural¯uid is sent for examination, the laboratory is often asked to determine whether it is a transudate or an exudate. In reality, the question being asked is`what is the cause of this effusion?'.
Although a review of the causes of pleural effusion in seven of the largest and most frequently cited studies showed that nearly half were due to cancer, the most common, but least reported, cause of pleural effusion is congestive cardiac failure. 4 These effusions are often small, bilateral and expected to be seen as part of the illness, so the diagnosis is obvious. 4 Some of the causes of pleural effusions are shown in Table 1 .
Thoracocentesis is usually technically uncomplicated, well tolerated and relatively safe. It can be performed on almost any pleural effusion. Pleural¯uid`taps' are carried out for two main reasons: the procedure may be therapeutic in alleviating the pulmonary compromise created by a large effusion; where the cause of a pleural effusion is unclear, biochemical analysis may help to provide a diagnosis. However, a diagnosis may not be established in up to 20% of exudates even after intensive evaluation. 5 The gross appearance of the¯uid may be helpful. Although most transudates and many exudates are clear, straw-coloured, odourless and non-viscous, a blood-stained, turbid, milky or viscous appearance may suggest a particular cause. 6 Non-biochemical tests, which may be diagnostic, include cytology demonstrating the presence of malignant cells and staining for microorganisms after appropriate culturing. The diagnostic yield of pleural¯uid cytology in malignant effusions has been reported to range from 40% to 87%. 2, 6 
TESTS USED IN THE BIOCHEMICAL ANALYSIS OF PLEURAL FLUIDS

Methodological considerations
The methods applied for the quantitation of substances in body¯uids have usually been established for serum and urine. Claims for satisfactory performance in body¯uids other than these are not usually made by the reagent manufacturers. Problems may be encountered with small volumes of viscous¯uids and with blood-stained and turbid¯uids; in addition, the variable protein content may lead to matrix effects, which are especially relevant when immunoassays are used. Particular problems may arise with slide methodologies in which adequate spreading of the sample is vital.
Samples should be collected into heparinized tubes to prevent clot formation and, especially if they are turbid, should be centrifuged prior to analysis; strongly blood-stained and turbid samples may be unsuitable for analysis. Lactate dehydrogenase (LDH) should not be measured in blood-stained¯uids. Samples for glucose analysis should be preserved adequately (e.g. with¯uoride), especially in samples that may be infected.
The analyte concentration may be outside the dynamic range of the assay and repeat analysis after appropriate dilution may be required. Conversely, values may be lower than those generally measured in serum, or decision cut-offs may lie in a variable and poorly performing range of the assay ± for instance, with cholesterol assay. 7 In addition, the choice of an appropriate quality-control sample is dif®cult.
Since normal¯uid is almost impossible to obtain, appropriate reference ranges have not been established and comparison with serum is usually made. Values given in the literature may not apply to the local method of analysis and results must be interpreted with respect to the local serum reference range (see later).
Original markers Total protein
The differentiation between transudate and exudate was originally based on the cell count, the presence or absence of clots in the¯uid and the speci®c gravity. 8 Later work concentrated on the use of¯uid protein concentration, a cut-off point of 30 g/L being used to separate transudates from exudates. Misclassi®cation of up to 8% of exudates, especially due to malignancies, and 15% of transudates has been found. 9 Others have found similar rates of misclassi®cation, although there was some improvement when pleural¯uid:serum ratios were used. 10, 11 Much poorer discrimination was reported in a group of elderly patients, with 29% of exudates and 29% of transudates being misclassi®ed. 12 In this study, however, all¯uids with a protein concentration above 49 g/L were found to be exudates. If arbitrary cut-off points are used to dichotomize data, the concept that the higher the protein value the greater the likelihood that the¯uid is an exudate is lost. This is evident from the receiver± operator curves (ROC) produced in the metaanalysis described later. 13 Lactate dehydrogenase (LDH) LDH activities much higher than those found simultaneously in serum were ®rst reported, in 1958, as a feature of effusions containing malignant cells. 14 Although a raised LDH activity was initially considered to be exclusive to malignant effusions, it seems to be characteristic of all in¯ammatory conditions of the pleura. 15, 16 In 1969, Chandrasekhar et al. 17 proposed that measurement of LDH activity in pleural¯uid was more effective than measuring the protein concentration in differentiating pleural exudates from transudates.
Light's criteria
In 1972, Light et al. 10 published the now classic criteria for giving as near 100% sensitivity and speci®city as possible in the identi®cation of an exudate ( Table 2) .
Both serum and pleural¯uid protein and LDH are measured, and¯uid is classi®ed as an exudate if any of the following criteria are met:
A pleural¯uid:serum protein ratio greater than 0´5. .
A pleural¯uid LDH activity above 200 U/L (later modi®ed to two-thirds of the upper limit of the serum reference range). .
A pleural¯uid:serum LDH ratio greater than 0´6.
It is thought that different physiological processes govern the protein and LDH content of the effusion, with higher pleural¯uid protein re¯ecting increased leakage or decreased clearance and higher LDH re¯ecting an active secretory process.
A critical assessment of Light's criteria
Although in the original study of Light et al. 10 only two of the 150 patients studied were misclassi®ed, giving a diagnostic sensitivity of 99% and speci®city of 98% for an exudate, other prospective studies using these criteria, while reproducing the sensitivity, reported much lower speci®cities (65±86%). 18±20 Light and colleagues used rigorous diagnostic criteria in their prospective study. Of their original 183 patients, 33 were excluded because the agreed diagnostic requirements were not met. It has been suggested that the low false-positive and false-negative results obtained were the result of these exclusions and that the diagnostic cut-offs could not, therefore, be applied to unselected populations. 19 Such an approach is, however, a prerequisite to establishing diagnostic criteria. It is therefore understandable that later use in less well de®ned populations resulted in lower diagnostic accuracy.
Additional reasons for the poorer diagnostic accuracy of later studies include the inappropriate use of an absolute LDH cut-off value of 200 IU/L. This value was originally proposed by Light et al. 10 and later, in order to account for different assay conditions, modi®ed by the same authors to two-thirds of the upper limit of normal for serum. 21 This vital modi®cation is often not appreciated, and widely differing diagnostic speci®cities were reported from two studies because an LDH of 200 IU/L represented the 88th centile of the upper limit of normal in one assay and the 43rd centile in the other. 22±24 Modi®cations of the original criteria with different cut-off values 13, 25, 26 are shown in Table 3 .
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Additional markers Cholesterol
The concentration of cholesterol is higher in exudates than in transudates, and its measurement has been proposed as a way of increasing diagnostic accuracy. 11 The reason is unknown; postulated mechanisms include release of cholesterol due to cellular degeneration and serum leakage re¯ecting increased pleural permeability. Of 70 effusions studied, the 31 transudates had a lower mean cholesterol concentration than both the malignant and other in¯ammatory effusions.
With a cut-off of 1´55 mmol/L (60 mg/dL), the malignant effusions were completely separated from the transudates. Three of the in¯ammatory effusions had a cholesterol concentration below this and were therefore erroneously classi®ed as transudates, giving an overall misclassi®cation rate of 5%. This contrasted with the use of Light's criteria, where all the exudates were correctly classi®ed but with an overall misclassi®cation rate of 16%. 11 Other groups have reviewed the use of cholesterol alone, 27 as a¯uid:serum ratio 28, 29 or in combination with LDH 24 (Table 4) .
On its own, cholesterol clearly reduces incorrect classi®cation and hence probable over-investigation of patients with transudates but at the expense of missing a signi®cant number of patients with exudates where further testing would be warranted. One point not considered by any of the authors is the accuracy and precision of the assay of cholesterol at these low concentrations.
Bilirubin
A pleural¯uid:serum bilirubin ratio of 40´6 was suggested as an alternative to Light's criteria for distinguishing exudates; this was also valid in four patients with jaundice. 30 In a study of 51 uids (half exudates and half transudates, with ®ve of undetermined cause), the diagnostic sensitivity was 96% and speci®city 83% compared with 90% and 82%, respectively, for Light's criteria. In the only other study of bilirubin assay for this purpose, it was con®rmed that the best results were obtained using a cut-off of 0´6, but in a group of 318 patients both the sensitivity and speci®city for detection of an exudate were found to be much lower (81% and 61%, respectively). 29 
Albumin gradient
One of the explanations put forward for the poor speci®city of Light's criteria, leading to signi®cant errors in the classi®cation of transudates, is the effect of previous diuretic therapy on the chemical composition of the effusion. Pillay 31 ®rst reported an increase in protein content from 15 to 29 g/L after diuretic therapy in patients with heart failure. This rise was con®rmed by Chakko et al., 32 who compared results from thoracocentesis at admission with those found after diuretic treatment. A signi®cant rise in protein concentration from 22 to 32 g/L and in¯uid:serum LDH ratio from 0´39 to 0´64 was found, the effusion characteristics changing from those of a transudate to those of an exudate in three patients.
This led Roth et al. 20 to extrapolate from work done on ascitic¯uid, where transudates with a high protein content may be a more common problem, and to suggest the use of a serum±effusion albumin gradient (serum albumin concentration minus effusion albumin concentration). The albumin gradient and Light's criteria were then compared in a study of 59 consecutive patients (but only 15 with heart failure). Using an albumin gradient of 12 g/L or below to indicate an exudate and more than 12 g/L to indicate a transudate led to correct classi®cation of all of the transudates, but incorrectly classi®ed two malignant effusions. Conversely,¯uids from ®ve patients of whom four had had previous diuretic therapy were misclassi®ed as exudates by Light's criteria, thus giving a speci®city of 100% for the albumin gradient compared with 72% for Light's criteria. Much poorer sensitivity and speci®city (87% and 92%, respectively) were found in the only other study of the albumin gradient, although use of the gradient signi®cantly reduced the misclassi®cation (as exudates) of effusions from patients receiving diuretic therapy. 29
Meta-analysis of tests used to distinguish transudates from exudates
A meta-analysis that meets most of the recommendations for performing such analyses 33 examined the accuracy of the tests used most frequently to separate exudative from transudative effusions either when used on their own or in combination. 13 As well as the original criteria of Light et al., 10 the authors used more suitablè cut-offs' by subjecting the meta-analysis data to ROC analysis. 34 As judged by the area under the curve, which is generally recognized as the most accurate method of comparing discriminative properties, 34 single tests except for the bilirubin ratio all performed reasonably well, although the protein ratio appeared marginally the best.
For tests used in combination, the highest odds ratios were found for pairs or triplets that included the albumin gradient. The combination of three tests tended to give the highest sensitivity and odds ratio, but (predictably) lower speci®city. However, extensive overlap of the con®dence intervals meant that no clearly superior combination could be selected.
Recommendations for choice of tests to distinguish exudates
Recommendations for a testing strategy should logically come from the meta-analysis of Heffner et al., 13 but, because of their ®ndings in which no clearly superior test or combination emerges, the choice of test(s) remains largely one of individual preference.
The following points should, however, be considered:
Bilirubin is not useful. .
Combinations of either two or three tests improve sensitivity but at the expense of speci®city; users must understand the principles of parallel testing and be clear about applying the`or' rule. .
If a single test is required, pleural¯uid protein performs as well as any other single test and has the advantage of being widely available, applicable to many different uids and yielding a similar reference range whatever method is used, so that values are virtually interchangeable between laboratories. There is the added advantage that the decision thresholds are in the optimized concentration area of the assay. .
Combination testing with individual tests that are highly correlated performs no better than the most diagnostically accurate test alone: thus, excluding the pleural¯uid LDH from Light's criteria did not diminish the accuracy of diagnosis. .
The accuracy of single tests or combinations is not enhanced by the use of¯uid:serum ratios or¯uid±serum gradients, except perhaps where there has been prior diuretic treatment.
Other tests and speci®c situations where these may be useful Glucose (`is it rheumatoid?')
Glucose measurement is frequently requested on pleural¯uid samples. The value of this is unclear; samples are often sent without¯uoride oxalate preservative and a concurrent serum glucose is rarely measured. A glucose concentration above 5´3 mmol/L (95 mg per 100 mL) is nearly always associated with a transudate. Although lower concentrations have been reported in exudates associated with bacterial infection, especially empyema and tuberculosis (TB) as well as in malignant disease, the concentration of glucose in exudates is extremely variable and these diagnoses are not excluded by a high or normal pleural¯uid glucose concentration. 35, 36 A pleural effusion is found in approximately 3% of patients with active rheumatoid arthritis. These effusions almost always have a low glucose concentration: values below 1´2±1´7 mmol/L (20±30 mg/dL) are found in 70±80% of cases and less than 0´6 mmol/L (10 mg/dL) in 42% of cases. 37 The differential diagnosis may include systemic lupus erythematosus, in which pleural effusion glucose concentrations are usually normal. 38 Differentiating a rheumatoid effusion therefore appears to be the only use of pleural¯uid glucose concentrations and measurement is usually unhelpful.
pH (`does this parapneumonic effusion need draining?')
The pH of the small amount of pleural¯uid present in normal individuals has been measured as 7´64. 39 This falls to about that of arterial blood when a pleural effusion develops. A pH of 57´30 suggests the presence of an in¯ammatory or in®ltrative process. 40 Unfortunately,malignant effusions often have a pH value above 7´3, which limits the utility of this measurement. It has been suggested, however, 41 that a low pH correlates with cytological evidence of malignancy, a shorter mean survival and poorer response to tetracycline pleurodesis. pH measurement may be useful in aiding decisions about drainage of a parapneumonic effusion. 42 Parapneumonic effusions occur in 20±57% of patients who require hospital admission for bacterial pneumonia. Some are complicated by the formation of intrapleural pus collection (empyema), when drainage is required. Since the diagnostic accuracy of clinical ®ndings and radiology in establishing which effusions require surgical intervention is poor and microbiological examination of the pleural¯uid has low diagnostic sensitivity, biochemical markers such as pH, glucose and LDH activity have all been recommended. 42, 43 Again, studies have been small and differing results have led to a lack of consensus. In a similar meta-analysis to that described earlier, Heffner et al. 44 examined this specialized situation. They concluded that pleural¯uid pH had higher diagnostic accuracy than pleural¯uid glucose or LDH.
Problems with pleural¯uid pH measurement include failure to recognize the importance of anaerobic collection, the need for prompt analysis and the possibility of clot formation in the blood gas analyser. 45, 46 Litmus paper is not a suitable alternative. 47 
Tumour markers (`is it malignant?')
Up to 50% of pleural effusions submitted for analysis come from patients with neoplastic disease. Cytological examination is usually carried out routinely but has a maximal diagnostic sensitivity of 50±60%. 4, 48 Tumour markers used in mainstream practice have been applied to pleural¯uid to try to improve the rate of diagnosis, but with differing results. Diagnostic sensitivities of 20±60% have been reported, with higher rates for pulmonary neoplasms. For example, one report on 74 patients with cancer showed that 50% had carcinoembryonic antigen (CEA) values above 5 mg/L, including nine out of 13 cases of lung cancer with negative cytological results on pleural¯uid. 49 Others have also reported that CEA measurement enhances the diagnosis of malignancy. 50, 51 However, falsepositive results are common: elevated CEA concentrations (410 mg/L) were found in 17 of 182 pleural effusions that were due to benign disease, especially in empyemas and complicated parapneumonic effusions. 52 Because of different assays, the cut-off values chosen to indicate malignancy differ, 53 but very high CEA concentrations are strongly indicative of malignancy. 49, 54 Reports of the usefulness of measuring neuron-speci®c enolase (NSE) to differentiate small-cell lung carcinoma are con¯icting. 54±56 One group considered the analysis helpful. However, all ten of their patients with small-cell lung carcinoma and cytologically negative pleural effusions had normal pleural¯uid NSE; thus the advantage over conventional cytology would seem to be negligible. 56 Studies of other tumour markers, including CA125, CA15-3, CA19-9 and squamous cell carcinoma antigen, have produced similar results, some authors reporting enhanced diagnostic effectiveness that is not con®rmed by others. 48, 53, 54, 57 CYFRA 21-1 (a tumour marker assay measuring soluble components of cytokeratin 19) has been reported to be useful in the diagnosis of squamous cell carcinoma and particularly in the diagnosis of mesothelioma. 50
Lipids (`is it a chylothorax?')
Occasionally, the question of whether an effusion indicates a chylothorax is raised. This is the accumulation of lymph or chyle in the thoracic cavity following a leak from the thoracic duct which may arise spontaneously and without apparent cause, or result from chest trauma or operation, or from erosion by a mediastinal or chest malignancy. 58 The diagnosis is usually suspected when milkȳ uid is recovered on thoracocentesis, although the gross appearance of the¯uid is not reliable. Total parenteral nutrition¯uid infused into the pleural space also appears milky and may cause diagnostic confusion, but the glucose concentration may be very high. Pseudochylous effusions, where there is accumulation of cholesterol and/or lecithin-or globulin-rich¯uid in long-standing pleural effusions, are indistinguishable in appearance, and blood-stained¯uids proved to be chylous just as frequently as non-chylous. 59 There was wide overlap in cholesterol values between chylous and non-chylous effusions in this study but marked differences in triglyceride concentrations. The authors estimated that¯uids with triglyceride concentrations above 1´24 mmol/L (110 mg/dL) had a 99% chance of being chylous whereas those with a concentration below 0´57 mmol/L (50 mg/dL) had no more than a 5% chance. Lipoprotein electrophoresis may be helpful by con®rming the presence of chylomicra. 60 Amylase (`is pancreatitis the cause?') Amylase has been reported to be raised in pleural effusions associated with pancreatitis, with or without pseudocyst formation. 61, 62 Four cases of pseudocyst rupture were diagnosed using pleural uid amylase measurement, but in all cases the serum amylase was also raised. 63 Amylase activity is also raised in effusions associated with oesophageal rupture and in approximately 10% of malignant effusions (salivary type), extremely high values being found in some adenocarcinomata of lung and ovary. 64 Since oesophageal rupture would usually be diagnosed by other means the diagnostic value of amylase measurement here seems questionable.
Adenosine deaminase and lysozyme (`is it TB?')
The diagnosis of pleural TB is often dif®cult. In populations with a relatively high prevalence, measurement of adenosine deaminase (ADA) activity released from activated lymphocytes appears to be useful in distinguishing TB as a cause of an effusion. 49, 65, 66 In a study from Mexico, all but one of 82 patients with a tuberculous effusion had an ADA 470 IU/L, and with this cut-off the sensitivity and speci®city for diagnosis of pleural TB were 98% and 96%, respectively. 67 A review of the literature totalling 706 patients with TB and 1545 patients without TB gave a sensitivity of 99% and speci®city of 89% with 116 falsepositive results, the majority from patients with cancer or empyema. 67 Wider application of ADA measurement has been recommended, especially in countries with a high prevalence of TB. Measurement is simple and cheap but limited by assay availability. Differing methodology may mean that an absolute cut-off is not appropriate.
A raised concentration of lysozyme has also been reported in tuberculous pleural effusions. 68 Pleural¯uid:serum ratios were signi®cantly higher in tuberculous effusion than with any other cause, including malignancy, but were highest in those patients with empyema. It was concluded that measurement of lysozyme in conjunction with ADA would give a sensitivity and speci®city of 100% in a population with a high incidence of TB. 69 Other analytes Measurement of a number of speci®c proteins such as orosomucoid, albumin, prealbumin, caeruloplasmin, a 2 -macroglobulin, IgG, IgA, IgM and IgE have all been studied in pleural uid but have not been related to the presence of speci®c disease. Increased b 2 -microglobulin concentrations have been reported in several diseases, including TB, leukaemia and lymphoma, and a high pleural¯uid:serum ratio has been noted in some autoimmune disorders. 70, 71 Marked overlap between values in malignant and benign disease limits the diagnostic usefulness. 72, 73 Pleural uid ferritin concentrationand¯uid:serum ferritin ratios have been suggested as distinguishing transudates from exudates, particularly in the diagnosis of malignant exudates, where very high concentrations may be seen. 51, 74 Others have not found ferritin to be so useful. 49, 75 Fibrin degradation products have been reported to be increased in patients with malignancy, pulmonary embolus and infected exudates. 76 Other proteins investigated include hyaluronic acid, defensins, pseudouridine and complement factors C3 and C4. 77±79 Both alkaline phosphatase and total creatine kinase activity have been shown to be higher in exudates than in transudates, alkaline phosphatase being especially high in some neoplastic and tuberculous effusions. Both compare poorly with Light's criteria in sensitivity and especially speci®city. 80 The creatine kinase isoenzyme BB has been suggested as being useful in differentiating pleural effusions caused by malignant conditions, but was diagnostic in only 20% of such patients. 81 Similarly, although the LDH isoenzyme pattern has been suggested to aid the diagnosis of malignancy, 82 a second study found no single isoenzyme pattern to be associated with a particular aetiology. 83 Pleural¯uid zinc, copper and iron ratios were not helpful in differentiating benign from malignant effusions, and no major differences in urate concentrations have been demonstrated. 80, 84, 85 An increased pleural¯uid urea or creatinine may be speci®c for diagnosis of urinothorax, when¯uid accumulates in the pleural space in urinary tract obstruction. 86 High lactic acid concentrations have been reported in both bacterial and tuberculous effusions, with intermediate values in effusions associated with malignancy. 87 Distinguishing tuberculous from malignant effusions may be aided by the measurement of cytokines produced from activated Tlymphocytes. Concentrations of interleukin 2 and interferon were signi®cantly higher in thē uid obtained from patients with tuberculous pleurisy than in those of malignancy. 88 The addition of tumour necrosis factor to ADA measurement augmented the sensitivity for diagnosis of TB. 89, 90 
CONCLUSIONS
A wide range of tests has been put forward as being useful in the investigation of pleural¯uid collections, with the dual aim of distinguishing transudative and exudative collections and establishing a cause. This has led to some advocating a blanket approach, with the routine measurement of protein, albumin, LDH, glucose and cholesterol along with simultaneous blood concentrations, 91 starkly contrasting with the views of others 92 who argue that only two tests ± total protein and cytological examination ± are routinely needed. An initial limited-testing strategy using total protein and LDH, with follow-up investigation only if the effusion has the characteristics of an exudate, has also been advocated. 19, 93 Nearly all studies concentrate on the utility of tests for correctly diagnosing an exudate, arguing that these are the effusions that require further investigation. All sampled larger numbers of exudates than transudates and, although this re¯ects the mix of samples sent to the laboratory, in clinical practice transudates are much more common ± but the cause is usually obvious. Since only dif®cult transudates are sampled, however, it could be argued that it is just as important to reach the correct diagnosis for thesē uids.
All the described studies concentrate on the diagnostic capability of individual tests, describing them in terms of sensitivity, speci®city, predictive value and likelihood ratios, and focus even more narrowly on the ability to classify an exudate correctly. 94 They do not consider how a result(s) integrates and interplays in a testing strategy. 95, 96 Because it is generally appreciated that no single test is 100% sensitive and speci®c, multiple tests are often performed. We do not know how multiple-test results are dealt with by physicians, particularly whether tests are combined using aǹ and' or an`or' rule. It is likely that the way in which they are used depends upon the prior estimates of likelihood of a particular disease. 96 Applying absolute decision thresholds takes no account of the prior probability of a result given other clinical ®ndings. For example, physicians will know whether a patient has received diuretic treatment, although they may not appreciate the effect this has on pleural¯uid chemistry. 32 Laboratory ®ndings may be given more weight if the history and physical ®ndings do not suggest a clear diagnosis. Most studies do not consider the other desirable test attributes of reliability, cost and availability, and none consider how the information will be used in patient management. 94, 96, 97 The aim of pleural¯uid testing is either to reach a diagnosis or, more rarely in the case of a parapneumonic effusion, to aid decisions over drainage. Despite criticisms by some of the preoccupation with distinguishing transudates from exudates, this probably remains a valid and valuable ®rst step, even though it does not establish the underlying cause of an effusion. 98, 99 A single test, such as total protein, may for most samples be suf®cient for this, with further tests in this initial evaluation being requested only if results lie in the grey areas around (arbitrary and empirically determined) decision thresholds. However, although this is a logical approach, in practical terms it may be easier to measure other analytes, such as cholesterol and LDH, simultaneously. Other chemical assays such as amylase, glucose and triglyceride concentration may be useful, but only if a speci®c question is being asked. If the sample is identi®ed as an exudate, then further tests, such as cytology, culture and ADA (if available), should be considered, again ideally depending on the clinical ®ndings and the likelihood of a particular disease being present. However, this logical and potentially effective stepwise approach requires close interaction between laboratory staff and clinicians.
